Your browser doesn't support javascript.
loading
Lin28b is involved in curcumin-reversed paclitaxel chemoresistance and associated with poor prognosis in hepatocellular carcinoma.
Tian, Nan; Shangguan, Wenbing; Zhou, Zuolin; Yao, Yao; Fan, Chunlei; Cai, Lijun.
Affiliation
  • Tian N; Institute of Molecular Medicine, Life Science College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
  • Shangguan W; Institute of Molecular Medicine, Life Science College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
  • Zhou Z; Institute of Molecular Medicine, Life Science College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
  • Yao Y; Institute of Molecular Medicine, Life Science College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
  • Fan C; Institute of Molecular Medicine, Life Science College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
  • Cai L; Department of gastroenterology, the First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
J Cancer ; 10(24): 6074-6087, 2019.
Article de En | MEDLINE | ID: mdl-31762817
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies / Risk_factors_studies Langue: En Journal: J Cancer Année: 2019 Type de document: Article Pays d'affiliation: Chine Pays de publication: Australie
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies / Risk_factors_studies Langue: En Journal: J Cancer Année: 2019 Type de document: Article Pays d'affiliation: Chine Pays de publication: Australie